Prelude Therapeutics Inc
PRLD
9 insider filings · Latest: May 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Apr 23 10:50 PM | David P BonitaDirector, 10% Owner | Purchase | 2,815,315 | $4.44 | $12.5M | 1,126,126(I) | View → |
| Apr 21, 2026 | Apr 23 10:48 PM | ORBIMED ADVISORS LLCDirector, 10% Owner | Purchase | 2,815,315 | $4.44 | $12.5M | 1,126,126(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 4 8:10 PM | Charles Q MorrisChief Medical Officer | Grant/Award | 450,000 | $4.70 | 450,000(D) | View → |
| Apr 27, 2026 | Apr 28 9:14 PM | RA CAPITAL MANAGEMENT, L.P.10% Owner | Other (J) | 1,407,000 | $0.0001 | 1,407,000(I) | View → |
| Apr 21, 2026 | Apr 22 8:15 PM | BAKER BROS. ADVISORS LPDirector, 10% Owner | Purchase | 2,252,252 | $0.0001 | 20,105,994(I) | View → |
| Feb 4, 2026 | Feb 5 9:14 PM | Andrew CombsChief Chemistry Officer | Grant/Award | 230,000 | $2.30 | 230,000(D) | View → |
| Feb 4, 2026 | Feb 5 9:12 PM | Peggy ScherleChief Scientific Officer | Grant/Award | 230,000 | $2.30 | 230,000(D) | View → |
| Feb 4, 2026 | Feb 5 9:11 PM | Bryant David LimCLO, CFO, Corp Sec. | Grant/Award | 275,000 | $2.30 | 275,000(D) | View → |
| Feb 4, 2026 | Feb 5 9:10 PM | Vaddi KrishnaDirector, CEO | Grant/Award | 837,000 | $2.30 | 837,000(D) | View → |